| Sam's Club Pharmacy #10-8226 | |
| 5550 S Clack St, Abilene, Texas 79606 | |
| (325) 793-2652 |
| Name | Sam's Club Pharmacy #10-8226 |
|---|---|
| Organization Name | Sams East Inc |
| Location | 5550 S Clack St, Abilene, Texas 79606 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (325) 793-2652 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Alimera Sciences Limited, the European subsidiary of Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced the availability of real world data from 28 injections of ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) in Europe, presented in a review paper authored by Fahd Quhill, Consultant Ophthalmologist, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, South Yorkshire, U.K.
The Los Angeles Times: - "Under pressure from state regulators, Anthem Blue Cross has agreed to postpone its controversial rate increases of up to 39% for individual health insurance policies set for March 1. In an unusual conference call, California Insurance Commissioner Steve Poizner said Anthem executives told him Saturday morning that its March rate hike would not take effect before May 1 for 800,000 individual policyholders in the state" (Lifsher, 2/13).
The Obama administration wrote a new chapter Wednesday in the "if you like your health plan, you can keep it" chronicles, decreeing that plans it once derided as "junk" or "substandard" can remain in effect until October 2017 - long after the next presidential election. The point, administration officials say, is to help those in the market for individual or small-group plans make a smoother transition into Obamacare (Jon Healey, 3/5).
A prediction score that included such factors as age, blood pressure, heart and respiratory rate for patients who received out-of-hospital emergency care was associated with the development of critical illness during hospitalization such as severe sepsis, the need for mechanical ventilation or death, according to a study in the August 18 issue of JAMA.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
› Verified 7 days ago
| NPI Number | 1639196793 |
| Organization Name | SAMS EAST INC |
| Doing Business As | SAMS PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5550 S Clack St, Abilene, TX 79606 |
| Phone Number | 325-793-2652 |
News Archive
Alimera Sciences Limited, the European subsidiary of Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced the availability of real world data from 28 injections of ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) in Europe, presented in a review paper authored by Fahd Quhill, Consultant Ophthalmologist, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, South Yorkshire, U.K.
The Los Angeles Times: - "Under pressure from state regulators, Anthem Blue Cross has agreed to postpone its controversial rate increases of up to 39% for individual health insurance policies set for March 1. In an unusual conference call, California Insurance Commissioner Steve Poizner said Anthem executives told him Saturday morning that its March rate hike would not take effect before May 1 for 800,000 individual policyholders in the state" (Lifsher, 2/13).
The Obama administration wrote a new chapter Wednesday in the "if you like your health plan, you can keep it" chronicles, decreeing that plans it once derided as "junk" or "substandard" can remain in effect until October 2017 - long after the next presidential election. The point, administration officials say, is to help those in the market for individual or small-group plans make a smoother transition into Obamacare (Jon Healey, 3/5).
A prediction score that included such factors as age, blood pressure, heart and respiratory rate for patients who received out-of-hospital emergency care was associated with the development of critical illness during hospitalization such as severe sepsis, the need for mechanical ventilation or death, according to a study in the August 18 issue of JAMA.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
› Verified 7 days ago
News Archive
Alimera Sciences Limited, the European subsidiary of Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced the availability of real world data from 28 injections of ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) in Europe, presented in a review paper authored by Fahd Quhill, Consultant Ophthalmologist, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, South Yorkshire, U.K.
The Los Angeles Times: - "Under pressure from state regulators, Anthem Blue Cross has agreed to postpone its controversial rate increases of up to 39% for individual health insurance policies set for March 1. In an unusual conference call, California Insurance Commissioner Steve Poizner said Anthem executives told him Saturday morning that its March rate hike would not take effect before May 1 for 800,000 individual policyholders in the state" (Lifsher, 2/13).
The Obama administration wrote a new chapter Wednesday in the "if you like your health plan, you can keep it" chronicles, decreeing that plans it once derided as "junk" or "substandard" can remain in effect until October 2017 - long after the next presidential election. The point, administration officials say, is to help those in the market for individual or small-group plans make a smoother transition into Obamacare (Jon Healey, 3/5).
A prediction score that included such factors as age, blood pressure, heart and respiratory rate for patients who received out-of-hospital emergency care was associated with the development of critical illness during hospitalization such as severe sepsis, the need for mechanical ventilation or death, according to a study in the August 18 issue of JAMA.
Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.
› Verified 7 days ago
Choice Medical Supply Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17 Windmill Cir, Abilene, Texas 79606 Phone: (325) 677-2250 | |
Cvs Pharmacy #07443 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 965 N Judge Ely Blvd, Abilene, Texas 79601 Phone: (325) 677-0616 | |
Cvs Pharmacy #07271 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4580 Buffalo Gap Rd, Abilene, Texas 79606 Phone: (325) 698-0651 | |
Hendrick Medical Supply Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1318 N 8th St, Abilene, Texas 79601 Phone: (325) 673-3711 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1209 E South 11th St, Abilene, Texas 79602 Phone: (325) 692-7059 |